Czirr James C's Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Oct 19, 2021
- Accession no.
- 0001493152-21-025776
- Filed
- Oct 19, 2021, 3:18 PM ET
- Trade date
- Oct 15, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $33.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Czirr James CCIK 0001260641 | Director, 10% Owner |
| 10X Fund, L.P.CIK 0001453356 | 10% Owner |
| 10X Capital Management, LLCCIK 0001457247 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | Common Stock | SSaleDisposed | −10,000 | $3.37 | −$33,700 | 6,218,940 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.